Contact
searchSearch
HMP Global

Health Care Economics

Expert Perspectives
Commentary Videos

conference coverage


CONFERENCE COVERAGE
AMCP Nexus 2025: New Data Reveal Access Delays and Clinical Risks in Alternative Funding Programs
10/28/2025
Juliet Gallagher
At AMCP Nexus 2025, Autumn D. Zuckerman, PharmD, BCPS, CSP, joined by Amy Niles, MBA, and Ashira Vantrees, Esq., unpacked 3 cost-shifting strategies that are reshaping access to specialty medicines: copay accumulators, copay maximizers, and...
At AMCP Nexus 2025, Autumn D. Zuckerman, PharmD, BCPS, CSP, joined by Amy Niles, MBA, and Ashira Vantrees, Esq., unpacked 3 cost-shifting strategies that are reshaping access to specialty medicines: copay accumulators, copay maximizers, and...
At AMCP Nexus 2025, Autumn D....
10/28/2025
First Report Managed Care
Conference Coverage
Strategies for Optimizing Free Drug Programs in a Changing Policy Landscape
04/29/2025
Juliet Gallagher
At Asembia 2025, experts from AcariaHealth detailed how strategic management of free drug programs can optimize outcomes for manufacturers and patients alike, while adapting to evolving regulatory and payer environments.
At Asembia 2025, experts from AcariaHealth detailed how strategic management of free drug programs can optimize outcomes for manufacturers and patients alike, while adapting to evolving regulatory and payer environments.
At Asembia 2025, experts from...
04/29/2025
First Report Managed Care
Conference Coverage
Balancing Innovation and Access: Managed Care Strategies to Navigate the Rising Cost of Oncology Treatments
04/24/2025
Grace Taylor, MS, MA
As oncology treatments grow more advanced and expensive, a panel of experts at AMCP 2025 reveal how managed care strategies are evolving to ensure both cost control and high-quality patient outcomes.
As oncology treatments grow more advanced and expensive, a panel of experts at AMCP 2025 reveal how managed care strategies are evolving to ensure both cost control and high-quality patient outcomes.
As oncology treatments grow more...
04/24/2025
First Report Managed Care
Conference Coverage
Successes and Challenges Ahead: Navigating Changes in IRA and Medicare Part D
10/18/2024
Hannah Musick
Explore the implications of the CY 2025 Medicare Part D Redesign and the Inflation Reduction Act with AMCP Nexus 2024 session speakers, addressing successes and challenges faced by stakeholders as they prepare for significant changes ahead.
Explore the implications of the CY 2025 Medicare Part D Redesign and the Inflation Reduction Act with AMCP Nexus 2024 session speakers, addressing successes and challenges faced by stakeholders as they prepare for significant changes ahead.
Explore the implications of the...
10/18/2024
First Report Managed Care
Conference Coverage
Cost-Effectiveness of MDMA-Assisted Therapy for PTSD
10/16/2024
Hannah Musick
Researchers at AMCP Nexus 2024 explored the cost-effectiveness of Midomafetamine-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) in US health care settings, with findings suggesting it may be a more cost-effective...
Researchers at AMCP Nexus 2024 explored the cost-effectiveness of Midomafetamine-assisted therapy (MDMA-AT) for post-traumatic stress disorder (PTSD) in US health care settings, with findings suggesting it may be a more cost-effective...
Researchers at AMCP Nexus 2024...
10/16/2024
First Report Managed Care
Conference Coverage
The Impact of Upfront Biomarker Testing on Total Cost of Care for Patients With aNSCLC and mCRC
10/14/2024
Hannah Musick
Multigene panel testing can increase eligibility for targeted therapy in lung and colorectal cancer patients while only representing a small portion of total care costs according to research presented at AMCP Nexus 2024.
Multigene panel testing can increase eligibility for targeted therapy in lung and colorectal cancer patients while only representing a small portion of total care costs according to research presented at AMCP Nexus 2024.
Multigene panel testing can...
10/14/2024
First Report Managed Care
Conference Coverage
Federal Trade Commission’s Report Highlights PBMs’ Influence Over Drug Costs and Access in the US
09/17/2024
Grace Taylor, MS, MA
In July 2024, the Federal Trade Commission (FTC) published an interim report discussing the impact that pharmacy benefit managers (PBMs) have on the accessibility and affordability of drugs in the US. The report was issued as part of an...
In July 2024, the Federal Trade Commission (FTC) published an interim report discussing the impact that pharmacy benefit managers (PBMs) have on the accessibility and affordability of drugs in the US. The report was issued as part of an...
In July 2024, the Federal Trade...
09/17/2024
First Report Managed Care
Conference Coverage
Evolving Payer Strategies for Rare and Specialty Disease Management: Insights from Asembia 2024
05/20/2024
Matt Dickinson, PharmD, MBA, Alnylam Pharmaceuticals, led a panel to highlight payer strategies for managing rare and specialty disease products and how they continue to evolve based on Alnylam Pharmaceuticals’ 2023 Rare and Specialty Trend...
Matt Dickinson, PharmD, MBA, Alnylam Pharmaceuticals, led a panel to highlight payer strategies for managing rare and specialty disease products and how they continue to evolve based on Alnylam Pharmaceuticals’ 2023 Rare and Specialty Trend...
Matt Dickinson, PharmD, MBA,...
05/20/2024
First Report Managed Care
Conference Coverage
Addressing Cost & Accessibility for Innovative Medicines: GLP-1s and Beyond
05/02/2024
Danielle Sposato
The rapid pace of innovation, rising costs of prescription drugs, and the need for transparency to ensure access and affordability in the pharmaceutical industry are discussed in a session at Asembia 2024.
The rapid pace of innovation, rising costs of prescription drugs, and the need for transparency to ensure access and affordability in the pharmaceutical industry are discussed in a session at Asembia 2024.
The rapid pace of innovation,...
05/02/2024
First Report Managed Care
Conference Coverage
The True Cost of Nonalcoholic Steatohepatitis Progression
04/11/2024
Hannah Musick
“These data show that the burden of care for NASH is substantial, and compared with those without progression, the annual costs per person with progression are at least 2-fold higher, with the gap increasing over time,” said researchers that...
“These data show that the burden of care for NASH is substantial, and compared with those without progression, the annual costs per person with progression are at least 2-fold higher, with the gap increasing over time,” said researchers that...
“These data show that the burden...
04/11/2024
First Report Managed Care

Behind the Bill

Behind the Bill
The Senate’s $3 Trillion Deal. Tax Relief Now, Medicaid Coverage Loss Later?
07/02/2025
Katie Hayes, MJ
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After weeks of behind-the-scenes wrangling and last-minute amendments, lawmakers have passed a sprawling tax-and-spending megabill that makes good on a long-standing Republican goal: making the 2017 Trump tax cuts...
The Senate has done it. After...
07/02/2025
First Report Managed Care
Behind the Bill
When a Cap Isn’t Just a Cap: How a Provider Tax Proposal Could Reshape Medicaid Financing
06/25/2025
Katie Hayes, MJ
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most consequential policies are often buried in the fine print. One such detail in the Senate Finance Committee’s latest tax and spending proposal would gradually cap provider taxes—a core funding tool states use to pull in...
In Washington, the most...
06/25/2025
First Report Managed Care
Behind the Bill
Rewriting the Safety Net? Inside the Senate’s Changes to Medicaid and the ACA
06/18/2025
Katie Hayes, MJ
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve been following the progress of the One Big Beautiful Bill Act (OBBBA), which started in the House with sweeping tax reforms and some eye-catching health care proposals. Now, the Senate has released its (highly...
Over the past few weeks, I’ve...
06/18/2025
First Report Managed Care
Behind the Bill
How States Might Respond to the One Big Beautiful Bill Act
06/11/2025
Katie Hayes, MJ
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill Act (OBBBA) still in the hands of the Senate, much of the national conversation has centered on what this legislation would do to federal coverage programs. But regardless of how the federal process unfolds,...
With the One Big Beautiful Bill...
06/11/2025
First Report Managed Care
Behind the Bill
Is the Affordable Care Act on the Chopping Block? What the One Big Beautiful Bill Act Tells Us.
06/04/2025
Katie Hayes, MJ
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of headline-grabbing debate over Medicaid work requirements, and the “One Big Beautiful Bill Act” remains in the Senate as they deliberate over several health care provisions. While the Medicaid provisions sparked most of the...
It’s been weeks of...
06/04/2025
First Report Managed Care
Behind the Bill
From House to Senate: The Journey of Cutting Medicaid
05/28/2025
Katie Hayes, MJ
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of Representatives narrowly passed the One Big Beautiful Bill Act (HR 1, 119th Congress) by a single vote, sending the sweeping tax and spending reconciliation package, backed by President Trump, to the Senate. With its...
Last week, the House of...
05/28/2025
First Report Managed Care
Behind the Bill
Eligibility, Paperwork, and Penalties: The Not-So-Hidden Costs of Medicaid ‘Reform’
05/21/2025
Katie Hayes, MJ
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week in health policy—a phrase that’s quickly becoming routine. This time, House Republicans advanced a sweeping budget reconciliation bill, designed to implement elements of the March budget resolution, with a...
It’s been another eventful week...
05/21/2025
First Report Managed Care
Behind the Bill
A Busy Week in Drug Pricing Policy: Aligning US Drug Prices With Global Standards?
05/14/2025
Katie Hayes, MJ
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for drug pricing policy. While I’d love to dig into the details of both President Trump’s latest executive order and the newest Republican bill that would cut Medicaid spending, we don’t have the time—and this isn’t...
It’s been a busy few days for...
05/14/2025
First Report Managed Care
BEHIND THE BILL
When Agencies Lose Power: How 3 Seismic Shifts are Transforming Pharmaceutical Regulation
05/07/2025
Katie Hayes, MJ
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months, the landscape of administrative law has undergone a transformation so profound that pharmaceutical executives, health care providers, and patients alike are struggling to navigate the new terrain. The Supreme...
In the span of just 9 months,...
05/07/2025
First Report Managed Care
Behind the Bill
The Medicare Paradox, Part 3: Strategic Trade Doesn’t Have to be a Zero-Sum Game
05/07/2025
Katie Hayes, MJ
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve examined the growing friction between the Section 232 pharmaceutical tariff investigations and the Medicare drug pricing reforms authorized by the Inflation Reduction Act (IRA). These 2 policy agendas—industrial...
Over the past 2 weeks, I’ve...
05/07/2025
First Report Managed Care

Trending Articles

Prajapati Podcast
Podcasts
Standardizing the Field of Digital Medicine: Insights from an Industry Expert
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consul...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates Consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
News
Identifying Large-Vessel Vasculitis in Polymyalgia Rheumatica: Key Clinical and Laboratory Red Flags
04/05/2024
Lisa Kuhns, PhD, MD
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for large-vessel vasculitis in isolated polymyalgia rheumatica (PMR) include inflammatory back pain, significant pelvic involvement, widespread lower extremity pain, marked inflammatory response indicated by specific lab...
Potential red flags for...
04/05/2024
First Report Managed Care
Jay Ackerman Headshot
Interview
AI's Impact on Value-Based Care Outcomes
05/07/2024
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence...
05/07/2024
First Report Managed Care
News
Patient Diagnosed With Clinically Isolated Syndrome After Traumatic Brain Injury: Case Study
05/30/2024
Grace Taylor, MS, MA
Researchers presented a case study of a 71-year-old White man who was diagnosed with clinically isolated syndrome (CIS) after experiencing a traumatic brain injury.
Researchers presented a case study of a 71-year-old White man who was diagnosed with clinically isolated syndrome (CIS) after experiencing a traumatic brain injury.
Researchers presented a case...
05/30/2024
First Report Managed Care
FY2025
Behind the Bill
Budget Squeeze for FY 2025: What It Means for HHS and Public Health
07/17/2024
Katie Hayes, MJ
FY 2025 planning shows potential budget cuts for HHS and FDA, which could limit their ability to enforce regulations and address key issues.
FY 2025 planning shows potential budget cuts for HHS and FDA, which could limit their ability to enforce regulations and address key issues.
FY 2025 planning shows potential...
07/17/2024
First Report Managed Care

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use